Single-Use Bioreactor Bags Market Report 2026

The single-use bioreactor bags market size has grown rapidly in recent years. It will grow from $2.57 billion in 2025 to $3.03 billion in 2026 at a compound annual growth rate (CAGR) of 18%. the growth in the historic period can be attributed to increasing adoption of disposable bioprocessing systems, growing shift from stainless steel to single use technologies, rising biopharmaceutical production volumes, expansion of contract manufacturing activities, increasing focus on cost efficient upstream processing.

The single-use bioreactor bags market size is expected to see rapid growth in the next few years. It will grow to $5.82 billion in 2030 at a compound annual growth rate (CAGR) of 17.7%. the growth in the forecast period can be attributed to growing demand for flexible biomanufacturing, increasing production of biologics and vaccines, rising investments in bioprocessing capacity, expansion of biopharma companies in emerging markets, increasing preference for contamination free operations. Major trends in the forecast period include technology advancements in film materials, innovations in single use bag durability, developments in high volume single use systems, research and developments in bioprocess optimization, advancements in automation and sensor integration.

The rising production of biologics and vaccines is expected to drive the growth of the single-use bioreactor bags market in the coming years. Biologics and vaccine production involves large-scale manufacturing of therapeutic proteins, monoclonal antibodies, and vaccines using cell culture processes. This increase is driven by the growing prevalence of chronic diseases, which creates higher demand for advanced therapeutics and preventive treatments. Single-use bioreactor bags facilitate this production by providing flexible, sterile, and contamination-free solutions that reduce cleaning requirements, accelerate batch turnover, and preserve product integrity. For instance, in May 2022, according to the European Pharmaceutical Review (EPR), a UK-based non-governmental organization, biologics are projected to significantly surpass sales of innovative small molecules over the next five years, with an anticipated $120 billion increase in sales by 2027. Consequently, the rising production of biologics and vaccines is propelling the growth of the single-use bioreactor bags market.

Major companies in the single-use bioreactor bags market are focusing on developing advanced products, such as specialized single-use reactors, to improve efficiency, enhance safety, and reduce operational complexity in biopharmaceutical manufacturing. Specialized single-use reactors are pre-sterilized, disposable bioprocessing containers engineered to meet the precise chemical and physical requirements of complex biologics, such as antibody-drug conjugates (ADCs). For instance, in September 2024, Merck KGaA, a Germany-based science and technology company, launched the Mobius ADC Reactor. It is the first single-use reactor specifically designed for ADC manufacturing, offering a 70% increase in efficiency compared to traditional stainless steel or glass reactors. The system features assemblies made with Ultimus Film technology, providing enhanced bag strength, improved durability, and leak resistance for handling potent compounds. It eliminates the need for labor-intensive cleaning, reduces cross-contamination risks and potent liquid waste, and enables faster and more flexible production of critical cancer therapies for ground handling operators.

In May 2025, Qosina Corporation, a US-based distributor of single-use medical and biopharmaceutical components, partnered with Sealed Air Corporation for an undisclosed amount. This partnership aims to expand the availability of NEXCEL BIO1250 bioprocessing bag film, support the production of single-use bioreactor bags, and streamline the supply chain for biopharmaceutical manufacturing applications. Sealed Air Corporation is a US-based provider of advanced packaging and material-science solutions.

Major companies operating in the single-use bioreactor bags market are Saint-Gobain Life Sciences, Thermo Fisher Scientific Inc., Merck KGaA, Corning Life Sciences, Cytiva, Entegris Inc., Sartorius AG, Getinge AB, TekniPlex Healthcare, Eppendorf SE, Repligen Corporation, Freudenberg Medical, ABEC Inc., PBS Biotech Inc., Cell Culture Company LLC, Synthecon Inc., CellBios Healthcare & Lifesciences Pvt. Ltd., Single Use Support GmbH, Cellexus Ltd., FlexBiosys Inc.

North America was the largest region in the single-use bioreactor bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bioreactor bags market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-use bioreactor bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the single-use bioreactor bags market by increasing costs of imported polymer films, sensors, and precision connectors used in bag manufacturing. The impact is most evident in large-scale bioproduction facilities and in regions such as North America and Europe that rely on global supply chains. To mitigate tariff effects, manufacturers are investing in regional production and material sourcing strategies. In some cases, tariffs have accelerated innovation in locally sourced, sustainable single-use bioprocessing materials.

Single-use bioreactor bags are flexible, disposable containers designed to support and cultivate biological cultures under controlled conditions. They offer a sterile environment for cell growth while eliminating the need for cleaning and sterilization between uses. These bags improve efficiency and minimize the risk of contamination in bioprocessing operations.

The main products of single-use bioreactor bags include 2D bioreactor bags, 3D bioreactor bags, orbital shaken bags, and stirred-tank bioreactor bags. 2D bioreactor bags are flexible, disposable vessels designed to support efficient cell culture and bioproduction processes, providing scalability, sterility, and ease of use for both laboratory and industrial applications. Major cell types include mammalian, bacterial, yeast, and others. These bags are available in scales ranging from lab-scale (< 50 L) to large-scale (>2,000 L). Key applications include bioproduction, research and development, cell culture, and media preparation. End-users comprise biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), research laboratories, and academic institutions.

The single-use bioreactor bags market consists of sales of sensors, adapters, filters, bag clamps, support frames, sampling ports. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.